15^th World Heart Congress

Welcome Message

Welcome to the 15th World Heart Congress, taking place on March 18–19, 2026, in the vibrant city of Paris, France. This premier event brings together cardiologists, researchers, healthcare professionals, and industry leaders from around the world to share the latest advances and innovations in cardiovascular medicine. Over two days, attendees will have the opportunity to engage with cutting-edge research, exchange clinical expertise, and foster collaborations that drive the future of heart health.

Join us in this unique gathering to explore breakthrough therapies, emerging technologies, and preventive strategies that are shaping cardiovascular care globally. Whether you are a seasoned expert or an emerging professional, the congress offers a dynamic platform to learn, network, and contribute to the shared mission of improving lives through better heart health.

Details of  Heart Congress 2026 Conference in:

About Conference

The 15th World Heart Congress is set to take place on March 18–19, 2026, in the iconic city of Paris, France. Building on the momentum of past editions, this prestigious global gathering will center on the theme "Uniting Global Cardiology: Innovations, Prevention, and Precision in Heart Health." The congress aims to unite leading cardiologists, researchers, healthcare professionals, and industry innovators to address the evolving challenges in heart and vascular health.

Cardiovascular diseases continue to be the leading cause of death worldwide, and this congress serves as a critical forum to explore cutting-edge advancements in prevention, diagnosis, and treatment. With a rich and dynamic scientific program, the 15th edition will feature plenary sessions, expert panels, oral and poster presentations, hands-on workshops, and networking forums—all designed to foster cross-disciplinary dialogue and drive forward-thinking solutions.

Participants will delve into current topics including cardiac imaging, interventional cardiology, heart failure management, artificial intelligence in diagnostics, wearable technology, regenerative therapies, and lifestyle-based prevention strategies. This congress will not only highlight evidence-based clinical practices but also emphasize the role of digital health tools, big data analytics, and personalized medicine in transforming cardiovascular care.

Beyond the academic program, attendees will have the opportunity to engage with peers from around the globe, forge new collaborations, and exchange perspectives that can inspire future breakthroughs. The congress also encourages emerging researchers and students to showcase their work, facilitating the next generation of leadership in cardiovascular science.

The 15th World Heart Congress in Paris promises to be a milestone event—merging science with innovation and global cooperation to improve heart health outcomes and create a healthier, more resilient future for all.

Who Should Attend?

Heart Congress 2026 welcomes cardiologists, surgeons, researchers, healthcare professionals, educators, industry leaders, policymakers, students, and trainees. This event provides a platform to connect, learn, and collaborate on advancing cardiovascular care and improving patient outcomes worldwide.
Target Audience are :

1.      Cardiologists and surgeons

2.      Interventional specialists

3.      Cardiovascular researchers

4.      Nurses and technicians

5.      Medical educators

6.      Students and trainees

7.      Pharma and biotech experts

8.      Medical device engineers

9.      Public health leaders

10.  Clinical trial managers

11.  Rehabilitation therapists

12.  Health IT professionals

13.  Nutrition and wellness coaches

14.  Emergency medicine doctors

15.  Primary care physicians

16.  Policy makers and regulators

17.  Hospital administrators

18.  Biomedical scientists

19.  Cardiac imaging specialists

Why Attend the 15th World Heart Congress

The 15th World Heart Congress, scheduled for March 18-19, 2026, in the iconic city of Paris, France, is a must-attend event for anyone dedicated to advancing cardiovascular care and exploring next-generation innovations. This prestigious congress will bring together leading cardiologists, surgeons, researchers, healthcare professionals, and industry pioneers from across the globe.

1. Discover Cutting-Edge Research and Innovations:

• Explore the newest breakthroughs in cardiology and cardiovascular medicine.
• Gain insights from the latest clinical trials and translational research.
• Learn about innovative technologies, devices, and treatment strategies.

2. Comprehensive Scientific Program:

• Keynote lectures from world-renowned cardiovascular experts.
• Engaging panel discussions on urgent and emerging topics.
• Hands-on workshops designed to enhance clinical and technical skills.
• Poster sessions highlighting original research and case studies.

3. Networking and Collaboration Opportunities:

• Connect with peers, mentors, and collaborators from multiple disciplines.
• Foster new partnerships with academic, clinical, and industry leaders.
• Build a global network for future research and professional exchange.

4. Addressing Challenges and Exploring Solutions:

• Engage in discussions on the growing burden of cardiovascular disease.
• Identify practical solutions through multidisciplinary perspectives.
• Share experiences and best practices from diverse healthcare systems.

5. Advancing Professional Development:

• Stay current with evolving trends and standards in cardiology.
• Enhance your career with global exposure and recognition.
• Contribute to the global conversation on heart health and patient care.

Dont miss this exceptional opportunity to be part of a global movement in cardiovascular science. Join us at the 15th World Heart Congress in Paris to exchange ideas, grow professionally, and shape the future of heart health. Register now and be a voice in the next era of cardiovascular medicine.

Sessions and Tracks

Track 01 - Cardiovascular Disease, Risk Factors, and Nutrition

Cardiovascular disease (CVD) remains a leading cause of global mortality and is strongly influenced by nutrition. Poor dietary habits contribute to vascular plaque formation and accelerate aging. High intake of ultra-processed foods correlates with increased risks of cardiovascular, coronary, and cerebrovascular conditions. Conversely, plant-based diets have shown a 40% reduction in heart failure risk and lower cardiovascular mortality.

• Atherosclerosis and hypertension influenced by diet
• Nutrient-specific cardiovascular impacts
• Role of dietary cholesterol
• Obesity and cardiovascular risks

Track 02 - Catheterization and Cardiovascular Interventions

This field focuses on catheter-based treatments for heart conditions. Through cardiac catheterization, clinicians diagnose and treat heart valve, muscle, or artery issues. Common interventions include coronary angioplasty and stenting. These procedures reduce post-op recovery time and minimize scarring and discomfort.

• Advances in interventional techniques
• Benefits and risks of cardiac catheterization
• Latest innovations in device-assisted interventions

Track 03 - Cardiometabolic Health: Diabetes, Obesity & Metabolism

Cardiometabolic health encompasses metabolic syndrome, diabetes, and obesity-related cardiovascular issues. Lifestyle factors like poor diet and inactivity contribute to high blood pressure, glucose levels, and cholesterol, increasing cardiac risk. Atherosclerosis links both metabolic and cardiac events, emphasizing prevention through lifestyle changes.

• Metabolic syndrome and cardiovascular complications
• Diabetes and heart failure
• Endocrine influences on obesity
• Metabolism and heart health

Track 04 - Acute Coronary Syndromes (ACS)

ACS results from decreased blood flow to the heart, often leading to tissue damage. Typical symptoms include chest pain radiating to the left arm or jaw, nausea, and sweating. ACS is categorized into STEMI, NSTEMI, and unstable angina. Women and older adults may show atypical symptoms.

• Clinical classifications and ECG diagnosis
• Risk assessment and symptom management
• Gender-based diagnostic differences

Track 05 - Cardio-Oncology

Cardio-oncology bridges cancer and heart care, addressing cardiovascular effects of cancer treatments. Risk factors like smoking, obesity, and aging impact both diseases. Chemotherapy and radiation can damage cardiac tissues, necessitating preventative strategies and monitoring during oncology treatment.

• Heart disease post-chemotherapy
• Radiation-induced cardiac damage
• Cardiac tumors and syndromes
• Cancer therapies and cardiac outcomes

Track 06 - Geriatric Cardiology

Geriatric cardiology focuses on diagnosing and managing heart conditions in older adults. Common conditions include arrhythmias, heart failure, and coronary artery disease. Aging exacerbates atherosclerosis and increases cardiovascular mortality, requiring specialized care strategies.

• Cardiovascular aging
• Frailty and multimorbidity in older patients
• Preventive cardiology for the elderly

Track 07 - Heart Failure and Cardiomyopathies

Heart failure arises when the heart can't pump efficiently. Contributing conditions include coronary artery disease and hypertension. Cardiomyopathies alter heart muscle structure and function, with types like hypertrophic and dilated cardiomyopathy increasing risk of arrhythmias and sudden cardiac death.

• Types of cardiomyopathy
• Early detection and symptom control
• Therapeutic strategies for chronic heart failure

Track 08 - Cardiac Imaging

Cardiac imaging enables non-invasive assessment of heart structures and function using MRI, CT, and echocardiography. These tools support accurate diagnosis of congenital defects, ischemia, and valve disorders while minimizing radiation exposure.

• CMR and cardiac CT
• Clinical and diagnostic applications
• Innovations in imaging techniques

Track 09 - Coronary Heart Diseases

Coronary artery disease results from plaque buildup, narrowing arteries and restricting blood flow. Symptoms range from chest pain to silent myocardial infarction. Key risk factors include smoking, high cholesterol, and inactivity. Treatment focuses on lifestyle changes and medical/surgical interventions.

• CAD risk and prevention
• Omega-3s and heart health
• Gender-specific risks
• Novel therapeutic approaches

Track 10 - Cardiac Regeneration

Cardiac regeneration investigates stem cell therapies and tissue engineering to repair heart tissue post-injury. Advances include progenitor cell transplantation, engineered cardiac tissue, and biomimetic heart valves, offering hope for reversing damage caused by infarction and heart failure.

• Cell-based therapies
• Heart tissue engineering
• Stem cell potential in cardiac repair

Track 11 - Cardiac Pharmacology

Cardiac pharmacology explores drug therapies for hypertension, arrhythmias, and ischemic heart disease. The field also intersects with neuropharmacology due to autonomic control of cardiac function, offering insight into complex cardiac-neural pathways.

• Medications for arrhythmias and hypertension
• Neuro-cardiac connections
• Drug safety and efficacy

Track 12 - Pulmonary Hypertension and Venous Thromboembolism

Pulmonary hypertension involves increased pressure in pulmonary arteries, leading to shortness of breath and fatigue. Venous thromboembolism includes deep vein thrombosis and pulmonary embolism, posing serious health threats. Early detection and anticoagulant therapy are vital.

• Pulmonary vascular remodeling
• Causes and treatment of VTE
• Diagnostic challenges and innovations

Track 13 - Interventional Cardiology and Heart Surgery

Interventional cardiology offers catheter-based solutions for coronary issues, reducing recovery time. Heart surgery includes valve repairs, bypass grafting, and transplants. Advances like robotic-assisted and off-pump surgeries enhance outcomes and patient safety.

• Angioplasty and stenting
• Robotic heart surgery
• Open vs. minimally invasive surgery

Track 14 - Current Research in Cardiology – Future Medicine

Ongoing research aims to revolutionize cardiology via digital health, AI diagnostics, new drug development, and bioengineering. Novel molecular strategies and precision medicine are shaping the future of heart care.

• AI in cardiology
• Molecular cardiology
• Next-gen diagnostic tools

Track 15 - Implantable Cardioverter-Defibrillator (ICD)

ICDs detect and correct life-threatening arrhythmias via defibrillation or pacing. They are key for patients at risk of sudden cardiac arrest. Innovations like subcutaneous string defibrillators offer faster implantation and remote monitoring options.

• ICD vs. traditional defibrillators
• Advances in implantable tech
• Mobile integration and patient safety

Market Analysis

The global heart health industry is witnessing transformative growth, fueled by the rising burden of cardiovascular diseases (CVDs), which remain the leading cause of death globally. As the 15th World Heart Congress brings together experts in cardiology, healthcare, and innovation, it is important to examine the evolving landscape of the heart health market and the strategic opportunities it presents.

In recent years, the heart health market has expanded significantly due to increasing cases of heart-related conditions, aging populations, sedentary lifestyles, and growing awareness about preventive cardiovascular care. Pharmaceutical developments targeting hypertension, cholesterol management, and heart failure continue to be central to cardiovascular care. Meanwhile, the medical device sector is thriving, with widespread use of implantable cardioverter defibrillators (ICDs), pacemakers, stents, and wearable monitoring devices. In parallel, diagnostic tools—ranging from imaging technologies to cardiac biomarker tests—are improving early detection and personalized treatment planning for heart conditions.

Geographically, North America leads the market, supported by advanced healthcare infrastructure and significant R&D investment. Europe remains a strong player with continued emphasis on innovation and healthcare policy initiatives, while the Asia-Pacific region is emerging as a high-growth area due to increased healthcare spending, rising disease prevalence, and improving access to care.

Key trends shaping the future of this industry include the growing adoption of digital health technologies and wearable devices, allowing real-time heart monitoring and patient engagement. Telemedicine and remote care solutions are becoming integral, especially in managing chronic cardiac conditions across large or underserved populations. The integration of artificial intelligence, predictive analytics, and genetic profiling is also paving the way for personalized medicine in cardiology, enabling more precise diagnosis and treatment.

As the heart health industry continues to evolve, in-depth market analysis provides critical insights for identifying opportunities, guiding research priorities, and fostering collaboration between pharmaceutical firms, medical device companies, healthcare providers, and technology innovators. The 15th World Heart Congress offers a global platform to share knowledge, accelerate advancements, and shape the future of cardiovascular care.